Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Experimental Oncology
  • Published:

p53 mutation is associated with high S-phase fraction in primary fallopian tube adenocarcinoma

Abstract

Fallopian tube carcinoma (FTC) is a rare but lethal gynaecological malignancy. Four out of seven FTCs were identified with three point missense mutations, one single base deletion and one silent point mutation in the p53 gene. Genital-type HPV sequences were not detected. The S-phase fraction of tumours with mutant and wild-type p53 was 25.74% (median) and 12.55% (median) respectively.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Purchase on Springer Link

Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Runnebaum, I., Köhler, T., Stickeler, E. et al. p53 mutation is associated with high S-phase fraction in primary fallopian tube adenocarcinoma. Br J Cancer 74, 1157–1160 (1996). https://doi.org/10.1038/bjc.1996.510

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1996.510

This article is cited by

Search

Quick links